ripekg:evaluation/RIPEABC7D27C0BF8128FA |
prov:used |
ripekg:study-design-evidence/RIPEABC7D27C0BF8128FA |
ripekg:study-design-evidence/RIPEABC7D27C0BF8128FA |
rdf:type |
rdfs:Resource |
ripekg:study-design-evidence/RIPEABC7D27C0BF8128FA |
rdf:type |
owl:Thing |
ripekg:study-design-evidence/RIPEABC7D27C0BF8128FA |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:study-design-evidence/RIPEABC7D27C0BF8128FA |
rdf:type |
ripe:StudyDesignEvidenceStudy design evidence |
ripekg:study-design-evidence/RIPEABC7D27C0BF8128FA |
rdf:type |
tido:Evidence |
ripekg:study-design-evidence/RIPEABC7D27C0BF8128FA |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEABC7D27C0BF8128FA |
ripekg:study-design-evidence/RIPEABC7D27C0BF8128FA |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEABC7D27C0BF8128FA |
ripekg:study-design-evidence/RIPEABC7D27C0BF8128FA |
ripe:concerns |
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
ripekg:study-design-evidence/RIPEABC7D27C0BF8128FA |
ripe:recruitmentEndDateExtractionRationale |
No recruitment finish date found after a full search of the document. |
ripekg:study-design-evidence/RIPEABC7D27C0BF8128FA |
ripe:recruitmentStartDateExtractionRationale |
No recruitment start date found after a full search of the document. |
ripekg:study-design-evidence/RIPEABC7D27C0BF8128FA |
ripe:studyEndDateExtractionRationale |
No study end date found after a full search of the document. |
ripekg:study-design-evidence/RIPEABC7D27C0BF8128FA |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEABC7D27C0BF8128FA-human-2-2 |
ripekg:study-design-evidence/RIPEABC7D27C0BF8128FA |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEABC7D27C0BF8128FA-inspectai-2-2 |